Exposure Therapy May Not Worsen Symptoms in Veterans With Comorbid PTSD, Substance Use Disorder
The findings of the study challenge concerns that exposure therapy may worsen symptoms in patients with PTSD, particularly when comorbid SUD is present.
The findings of the study challenge concerns that exposure therapy may worsen symptoms in patients with PTSD, particularly when comorbid SUD is present.
Researchers conducted a multicenter randomized controlled trial of 214 veterans with PTSD from January 2012 through September 2013.
Researchers found that significant improvement in symptoms of posttraumatic stress disorder is associated with a lower risk for type 2 diabetes among veterans.
Violent behavior, alcohol use, and suicidal ideation were associated with suicide attempts by veterans, both prior to admission into specialized intensive PTSD programs run by the Veterans Health Administration and after discharge.
After 30 years, eye movement desensitization and reprocessing (EMDR) therapy continues to gain support as a beneficial treatment for a wide range of mental health conditions, especially post-traumatic stress disorder.
Intermittent theta-burst stimulation was associated with improved social and occupational function in veterans with PTSD.
Among veterans with PTSD, all-cause mortality is elevated, especially death from suicide, accidental injury, and viral hepatitis.
The Food and Drug Administration (FDA) has granted Breakthrough Status designation to NightWare (NightWare, Inc.), a digital intervention therapy that measures and treats nightmares in patients with post traumatic stress disorder (PTSD).
Integrated prolonged exposure therapy had a greater reduction in PTSD symptoms than integrated coping skills therapy, while both therapies resulted in comparable decreases in drinking.
Experts discuss how differentiation between the PTSD and TBI is important for the purposes of disability evaluation and treatment.